GALEOTTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.147
AS - Asia 4.254
EU - Europa 3.695
SA - Sud America 570
Continente sconosciuto - Info sul continente non disponibili 152
AF - Africa 138
OC - Oceania 47
Totale 18.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.955
SG - Singapore 1.356
GB - Regno Unito 1.329
CN - Cina 827
IT - Italia 783
HK - Hong Kong 461
BR - Brasile 402
VN - Vietnam 368
DE - Germania 270
BD - Bangladesh 251
SE - Svezia 250
TR - Turchia 233
FI - Finlandia 184
FR - Francia 175
IN - India 132
RU - Federazione Russa 122
UA - Ucraina 121
KR - Corea 108
ID - Indonesia 100
CA - Canada 95
AR - Argentina 72
BG - Bulgaria 69
JP - Giappone 69
PL - Polonia 53
MX - Messico 51
PK - Pakistan 48
GR - Grecia 40
TH - Thailandia 40
MY - Malesia 36
AU - Australia 34
CH - Svizzera 33
ES - Italia 33
NL - Olanda 32
IR - Iran 30
CL - Cile 27
LT - Lituania 27
IQ - Iraq 26
RS - Serbia 26
ZA - Sudafrica 26
TN - Tunisia 24
DZ - Algeria 23
EG - Egitto 22
AT - Austria 19
CO - Colombia 19
SA - Arabia Saudita 19
AE - Emirati Arabi Uniti 18
BE - Belgio 17
PT - Portogallo 17
UZ - Uzbekistan 17
MA - Marocco 16
RO - Romania 16
DK - Danimarca 15
PH - Filippine 15
QA - Qatar 15
NZ - Nuova Zelanda 13
VE - Venezuela 13
IE - Irlanda 12
EC - Ecuador 11
LB - Libano 11
SI - Slovenia 11
TW - Taiwan 11
IL - Israele 10
NP - Nepal 10
PE - Perù 9
CR - Costa Rica 8
HR - Croazia 8
AZ - Azerbaigian 7
BO - Bolivia 7
ET - Etiopia 7
CZ - Repubblica Ceca 6
EU - Europa 6
HN - Honduras 6
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 5
MO - Macao, regione amministrativa speciale della Cina 5
UY - Uruguay 5
CU - Cuba 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
NG - Nigeria 4
NO - Norvegia 4
PY - Paraguay 4
UG - Uganda 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
MK - Macedonia 3
NI - Nicaragua 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BZ - Belize 2
CI - Costa d'Avorio 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
Totale 17.828
Salva come PNG Salva come JPEG
Città #
Singapore 988
Southend 944
Ashburn 826
Santa Clara 754
Fairfield 717
Woodbridge 466
Chandler 458
Hong Kong 447
San Jose 362
Houston 316
Seattle 283
Council Bluffs 237
Cambridge 235
Dearborn 222
Beijing 221
Wilmington 221
Nyköping 210
London 169
Jacksonville 155
Ann Arbor 151
Modena 141
Helsinki 132
New York 114
Ho Chi Minh City 109
Los Angeles 104
The Dalles 100
Hefei 86
Hanoi 84
Izmir 81
Atlanta 66
Dallas 64
Redwood City 61
Sofia 61
Jakarta 59
Milan 55
Princeton 55
Seoul 55
Eugene 54
Lauterbourg 45
San Diego 43
Leipzig 41
Shanghai 41
Dong Ket 40
Buffalo 39
Istanbul 38
Tokyo 38
São Paulo 35
Rome 34
Moscow 32
Chicago 30
Columbus 30
Munich 30
Hillsboro 26
Bangkok 24
Orem 23
San Francisco 23
Belgrade 22
Mexico City 22
Ankara 21
Chennai 21
Nuremberg 20
Phoenix 20
Guangzhou 18
Jinan 18
Turku 18
Belo Horizonte 17
Denver 17
Falkenstein 17
Naples 17
Redondo Beach 17
Florence 16
Montreal 16
Bologna 15
Doha 15
Frankfurt am Main 15
Haiphong 15
Parma 15
Stockholm 15
Tashkent 15
Boardman 14
Brussels 14
Manchester 14
Rio de Janeiro 14
Warsaw 14
Amsterdam 13
Basingstoke 13
Delhi 13
Falls Church 13
Madrid 13
Paris 13
Boston 12
Brooklyn 12
Curitiba 12
Kunming 12
San Giuliano Milanese 12
Zhengzhou 12
Athens 11
Hamilton 11
Lahore 11
Ottawa 11
Totale 11.141
Salva come PNG Salva come JPEG
Nome #
Oral bioavailability and pharmacokinetic of non-animal chondroitin sulfate and its constituents in healthy male volunteers 1.823
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 720
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 713
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 634
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 508
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 472
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 360
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 350
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 344
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 342
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 339
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 337
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 333
Comparative analysis of fatty acid profile in three eutardigrade species 328
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 322
Analysis of glycosaminoglycan-derived, pre-column 2-aminoacridone-labeled disaccharides using liquid chromatography-fluorescence and -mass spectrometric detection. 314
Recent advances on separation and characterization of human milk oligosaccharides. 309
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 308
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 301
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 300
Isolation and structural characterization of chondroitin sulfate from bony fishes 297
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 290
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 289
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 289
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 278
Human milk glycosaminoglycans: the state of the art and future perspectives 277
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 273
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 266
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 264
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 259
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 257
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 256
High quality Green (Brazilian) propolis extracts characterized for active biomolecules exert epigenetic effects able to have a positive influence on cell oxidative stress 256
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 255
PURIFICATION OF PROPOLIS FROM POLYCYCLIC AROMATIC HYDROCARBONS AND PRESERVATION OF ACTIVE POLYPHENOL COMPONENT. 255
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 247
Mucopolysaccharidosis type II: preliminary data on glycosaminoglycan levels and structure in mice at baseline and after 6 weeks treatment with ERT 245
Human milk glycosaminoglycans. Handbook on dietary and nutritional aspects of human breast milk 238
Glycosaminoglycan profiling as a novel pan-cancer minimally invasive systems biomarker. 238
Breast Cyst Fluid Heparan Sulfate is Distinctively N-sulfated Depending on Apocrine or Flattened Type 235
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 235
Water Soluble Ppropolis (Greit120) and Human Interferon – α (HuIFN-AlfaN3) shows Anti – Influenza virus activity in vitro 230
Structural definition of terrestrial chondroitin sulfate of various origin and repeatability of the production process 223
Plasma glycosaminoglycan scores in early stage renal cell carcinoma 218
Oligosaccharide mapping of heparinase I-treated heparins by hydrophilic interaction liquid chromatography separation and online fluorescence detection and electrospray ionization-mass spectrometry characterization. 214
Chemical composition and antioxidant activity of propolis prepared in different forms and in different solvents useful for finished products 213
Approccio globale alle mucopolisaccaridosi: creazione piattaforma web-based 208
Selective removal of keratan sulfate in chondroitin sulfate samples by sequential precipitation with ethanol 207
Determination of total and single species of all uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for a possible early diagnosis of mucopolysaccharidoses 204
High-throughput determination of urinary hexosamines in newborns of 2-3 days of age: application for the early diagnosis of mucopolysaccharidoses 199
CHARACTERIZED PROPOLIS EXTRACTS, OBTAINED WITH STANDARDIZED EXTRACTION METHOD, SHOWN SIMILAR CHEMICAL PROFILE (HPLC-ESI-MSN) AND IN VITRO ANTIBACTERIAL, ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY TROUGH EVALUATION OF EXPRESSION OF miRNAS, mRNAS AND PROTEINS 185
Rigon L, Maccari F, Salvalaio M, Legnini E, D’Avanzo F, Galeotti F, Mantovani V, Gabrielli O, Marin O, Scarpa M, Volpi N, Tomanin R. Glycosaminoglycan profile in the Mucopolysaccharidosis type II mouse model at baseline and after 6 weeks treatment with ERT 177
Variazioni del dermatan solfato plasmatico durante la terapia enzimatica sostitutiva con iduronato-2-solfatasi in un paziente affetto da mucopolisaccaridosi II 159
Human milk glycosaminoglycan composition from women of different countries: a pilot study 154
Propolis: innovation and new applications based on its fine structural composition 151
Noninvasive detection of any-stage cancer using free glycosaminoglycans 125
Urinary Free Glycosaminoglycans Identify Adults at High Risk of Developing Early-stage High-grade Bladder Cancer 113
Mucopolisaccaridosi: approcci analitici alla diagnosi asintomatica. 67
Totale 18.003
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.012 0 120 70 53 32 55 46 44 169 106 171 146
2022/20231.368 128 147 103 147 113 192 25 179 152 24 67 91
2023/20241.163 49 67 44 178 237 102 115 136 27 41 63 104
2024/20252.689 100 76 56 184 541 397 183 198 299 112 212 331
2025/20264.901 174 96 299 416 767 303 633 286 501 508 445 473
2026/20271.874 1.636 238 0 0 0 0 0 0 0 0 0 0
Totale 18.003